Cytokine-induced memory-like natural killer cells for cancer immunotherapy
Abstract Natural killer cells are an important part of the innate immune system mediating robust responses to virus-infected and malignant cells without needing prior antigen priming. NK cells have always been thought to be short-lived and with no antigen specificity; however, recent data support th...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71996d026732453292130b7c623ad196 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:71996d026732453292130b7c623ad196 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:71996d026732453292130b7c623ad1962021-12-05T12:05:41ZCytokine-induced memory-like natural killer cells for cancer immunotherapy10.1186/s13287-021-02655-51757-6512https://doaj.org/article/71996d026732453292130b7c623ad1962021-12-01T00:00:00Zhttps://doi.org/10.1186/s13287-021-02655-5https://doaj.org/toc/1757-6512Abstract Natural killer cells are an important part of the innate immune system mediating robust responses to virus-infected and malignant cells without needing prior antigen priming. NK cells have always been thought to be short-lived and with no antigen specificity; however, recent data support the presence of NK cell memory including in the hapten-specific contact hypersensitivity model and in certain viral infections. The memory-like features can also be generated by short-term activation of both murine and human NK cells with cytokine combination of IL-12, IL-15 and IL-18, imparting increased longevity and enhanced anticancer functionality. Preclinical studies and very early clinical trials demonstrate safety and very promising clinical activity of these cytokine-induced memory-like (CIML) NK cells, making them an attractive cell type for developing novel adoptive cellular immunotherapy strategies. Furthermore, efforts are on to arm them with novel gene constructs for enhanced tumor targeting and function.Mubin TarannumRizwan RomeeBMCarticleNatural killer cellsCytokine-induced memory-like NK cellsInnate memoryCancer immunotherapyAdoptive cell therapyMedicine (General)R5-920BiochemistryQD415-436ENStem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Natural killer cells Cytokine-induced memory-like NK cells Innate memory Cancer immunotherapy Adoptive cell therapy Medicine (General) R5-920 Biochemistry QD415-436 |
spellingShingle |
Natural killer cells Cytokine-induced memory-like NK cells Innate memory Cancer immunotherapy Adoptive cell therapy Medicine (General) R5-920 Biochemistry QD415-436 Mubin Tarannum Rizwan Romee Cytokine-induced memory-like natural killer cells for cancer immunotherapy |
description |
Abstract Natural killer cells are an important part of the innate immune system mediating robust responses to virus-infected and malignant cells without needing prior antigen priming. NK cells have always been thought to be short-lived and with no antigen specificity; however, recent data support the presence of NK cell memory including in the hapten-specific contact hypersensitivity model and in certain viral infections. The memory-like features can also be generated by short-term activation of both murine and human NK cells with cytokine combination of IL-12, IL-15 and IL-18, imparting increased longevity and enhanced anticancer functionality. Preclinical studies and very early clinical trials demonstrate safety and very promising clinical activity of these cytokine-induced memory-like (CIML) NK cells, making them an attractive cell type for developing novel adoptive cellular immunotherapy strategies. Furthermore, efforts are on to arm them with novel gene constructs for enhanced tumor targeting and function. |
format |
article |
author |
Mubin Tarannum Rizwan Romee |
author_facet |
Mubin Tarannum Rizwan Romee |
author_sort |
Mubin Tarannum |
title |
Cytokine-induced memory-like natural killer cells for cancer immunotherapy |
title_short |
Cytokine-induced memory-like natural killer cells for cancer immunotherapy |
title_full |
Cytokine-induced memory-like natural killer cells for cancer immunotherapy |
title_fullStr |
Cytokine-induced memory-like natural killer cells for cancer immunotherapy |
title_full_unstemmed |
Cytokine-induced memory-like natural killer cells for cancer immunotherapy |
title_sort |
cytokine-induced memory-like natural killer cells for cancer immunotherapy |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/71996d026732453292130b7c623ad196 |
work_keys_str_mv |
AT mubintarannum cytokineinducedmemorylikenaturalkillercellsforcancerimmunotherapy AT rizwanromee cytokineinducedmemorylikenaturalkillercellsforcancerimmunotherapy |
_version_ |
1718372261777375232 |